nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2B6—Artemether—malaria	0.0746	0.0895	CbGbCtD
Ketamine—CYP2C8—Sulfadiazine—malaria	0.0664	0.0797	CbGbCtD
Ketamine—CYP2C8—Pyrimethamine—malaria	0.0664	0.0797	CbGbCtD
Ketamine—CYP3A4—Clindamycin—malaria	0.0469	0.0563	CbGbCtD
Ketamine—CYP2C9—Sulfadiazine—malaria	0.0463	0.0556	CbGbCtD
Ketamine—CYP2C9—Pyrimethamine—malaria	0.0463	0.0556	CbGbCtD
Ketamine—PTGS1—Dapsone—malaria	0.0449	0.0539	CbGbCtD
Ketamine—CYP2B6—Quinidine—malaria	0.0397	0.0477	CbGbCtD
Ketamine—CYP2C9—Artemether—malaria	0.0394	0.0473	CbGbCtD
Ketamine—CYP2C9—Proguanil—malaria	0.037	0.0445	CbGbCtD
Ketamine—CYP2C8—Quinine—malaria	0.0342	0.0411	CbGbCtD
Ketamine—CYP2C8—Quinidine—malaria	0.0301	0.0361	CbGbCtD
Ketamine—CYP3A4—Sulfadiazine—malaria	0.0269	0.0323	CbGbCtD
Ketamine—CYP2C8—Dapsone—malaria	0.0259	0.0311	CbGbCtD
Ketamine—CYP2C9—Quinine—malaria	0.0239	0.0286	CbGbCtD
Ketamine—ABCB1—Quinine—malaria	0.0232	0.0278	CbGbCtD
Ketamine—CYP3A4—Artemether—malaria	0.0229	0.0275	CbGbCtD
Ketamine—CYP3A4—Proguanil—malaria	0.0215	0.0258	CbGbCtD
Ketamine—CYP2C9—Quinidine—malaria	0.021	0.0252	CbGbCtD
Ketamine—CYP3A4—Doxycycline—malaria	0.0204	0.0245	CbGbCtD
Ketamine—ABCB1—Quinidine—malaria	0.0204	0.0244	CbGbCtD
Ketamine—CYP2C9—Dapsone—malaria	0.0181	0.0217	CbGbCtD
Ketamine—CYP3A4—Quinine—malaria	0.0139	0.0167	CbGbCtD
Ketamine—CYP3A4—Quinidine—malaria	0.0122	0.0146	CbGbCtD
Ketamine—CYP3A4—Dapsone—malaria	0.0105	0.0126	CbGbCtD
Ketamine—Nystagmus—Quinidine barbiturate—malaria	0.00337	0.0326	CcSEcCtD
Ketamine—Laryngospasm—Quinidine barbiturate—malaria	0.00322	0.0312	CcSEcCtD
Ketamine—Respiratory depression—Quinidine barbiturate—malaria	0.00319	0.031	CcSEcCtD
Ketamine—Pulmonary function test decreased—Quinidine barbiturate—malaria	0.00319	0.031	CcSEcCtD
Ketamine—TACR1—hematopoietic system—malaria	0.00308	0.057	CbGeAlD
Ketamine—Apnoea—Quinidine barbiturate—malaria	0.00284	0.0275	CcSEcCtD
Ketamine—Anaphylactic shock—Pyrimethamine—malaria	0.00252	0.0244	CcSEcCtD
Ketamine—Erythema—Proguanil—malaria	0.0024	0.0233	CcSEcCtD
Ketamine—Anorexia—Pyrimethamine—malaria	0.0024	0.0233	CcSEcCtD
Ketamine—Salivary hypersecretion—Pentoxifylline—malaria	0.00233	0.0226	CcSEcCtD
Ketamine—Decreased appetite—Pyrimethamine—malaria	0.00219	0.0212	CcSEcCtD
Ketamine—TACR1—digestive system—malaria	0.00214	0.0397	CbGeAlD
Ketamine—OPRD1—kidney—malaria	0.00205	0.038	CbGeAlD
Ketamine—TACR1—blood—malaria	0.00204	0.0378	CbGeAlD
Ketamine—Diplopia—Quinidine—malaria	0.00194	0.0188	CcSEcCtD
Ketamine—Diplopia—Quinine—malaria	0.00194	0.0188	CcSEcCtD
Ketamine—Anorexia—Proguanil—malaria	0.00187	0.0181	CcSEcCtD
Ketamine—CYP2C8—blood plasma—malaria	0.00186	0.0344	CbGeAlD
Ketamine—Diplopia—Quinidine barbiturate—malaria	0.00175	0.0169	CcSEcCtD
Ketamine—OPRM1—hematopoietic system—malaria	0.00171	0.0316	CbGeAlD
Ketamine—Decreased appetite—Proguanil—malaria	0.0017	0.0165	CcSEcCtD
Ketamine—PTGS1—endothelium—malaria	0.0017	0.0314	CbGeAlD
Ketamine—GRIN2C—brain—malaria	0.00167	0.0309	CbGeAlD
Ketamine—CYP2B6—blood plasma—malaria	0.00167	0.0309	CbGeAlD
Ketamine—CYP2C9—blood plasma—malaria	0.00165	0.0305	CbGeAlD
Ketamine—Vomiting—Pyrimethamine—malaria	0.0016	0.0155	CcSEcCtD
Ketamine—GRIN2D—brain—malaria	0.00155	0.0288	CbGeAlD
Ketamine—PTGS1—blood plasma—malaria	0.00151	0.0279	CbGeAlD
Ketamine—GRIN3A—brain—malaria	0.00146	0.027	CbGeAlD
Ketamine—GRIN1—brain—malaria	0.00139	0.0256	CbGeAlD
Ketamine—Convulsion—Sulfadiazine—malaria	0.00138	0.0134	CcSEcCtD
Ketamine—Bradycardia—Quinidine—malaria	0.00136	0.0132	CcSEcCtD
Ketamine—Bradycardia—Quinine—malaria	0.00136	0.0132	CcSEcCtD
Ketamine—GRIN2B—brain—malaria	0.00132	0.0245	CbGeAlD
Ketamine—Anaphylactic shock—Sulfadiazine—malaria	0.0013	0.0126	CcSEcCtD
Ketamine—TACR1—brain—malaria	0.00127	0.0235	CbGeAlD
Ketamine—CYP3A4—blood plasma—malaria	0.00126	0.0233	CbGeAlD
Ketamine—Vomiting—Proguanil—malaria	0.00125	0.0121	CcSEcCtD
Ketamine—Anorexia—Sulfadiazine—malaria	0.00124	0.012	CcSEcCtD
Ketamine—Rash—Proguanil—malaria	0.00124	0.012	CcSEcCtD
Ketamine—Dermatitis—Proguanil—malaria	0.00124	0.012	CcSEcCtD
Ketamine—Bradycardia—Quinidine barbiturate—malaria	0.00123	0.0119	CcSEcCtD
Ketamine—Erythema—Dapsone—malaria	0.00123	0.0119	CcSEcCtD
Ketamine—Erythema—Clindamycin—malaria	0.00119	0.0115	CcSEcCtD
Ketamine—Erythema—Quinidine—malaria	0.00117	0.0113	CcSEcCtD
Ketamine—Erythema—Quinine—malaria	0.00117	0.0113	CcSEcCtD
Ketamine—Nausea—Proguanil—malaria	0.00116	0.0113	CcSEcCtD
Ketamine—Vision blurred—Dapsone—malaria	0.00116	0.0112	CcSEcCtD
Ketamine—GRIN2A—brain—malaria	0.00116	0.0214	CbGeAlD
Ketamine—OPRM1—blood—malaria	0.00113	0.0209	CbGeAlD
Ketamine—Decreased appetite—Sulfadiazine—malaria	0.00113	0.011	CcSEcCtD
Ketamine—Vision blurred—Quinine—malaria	0.0011	0.0106	CcSEcCtD
Ketamine—Vision blurred—Quinidine—malaria	0.0011	0.0106	CcSEcCtD
Ketamine—Arrhythmia—Pentoxifylline—malaria	0.00108	0.0104	CcSEcCtD
Ketamine—Erythema—Quinidine barbiturate—malaria	0.00105	0.0102	CcSEcCtD
Ketamine—Erythema—Pentoxifylline—malaria	0.00105	0.0102	CcSEcCtD
Ketamine—OPRD1—brain—malaria	0.00103	0.0191	CbGeAlD
Ketamine—CYP2C8—hematopoietic system—malaria	0.00103	0.019	CbGeAlD
Ketamine—Convulsion—Quinine—malaria	0.00101	0.00979	CcSEcCtD
Ketamine—Convulsion—Quinidine—malaria	0.00101	0.00979	CcSEcCtD
Ketamine—Vision blurred—Quinidine barbiturate—malaria	0.000991	0.00961	CcSEcCtD
Ketamine—Vision blurred—Pentoxifylline—malaria	0.000989	0.00959	CcSEcCtD
Ketamine—OPRK1—brain—malaria	0.000987	0.0183	CbGeAlD
Ketamine—Anaphylactic shock—Clindamycin—malaria	0.000969	0.0094	CcSEcCtD
Ketamine—Shock—Quinidine—malaria	0.000936	0.00907	CcSEcCtD
Ketamine—Shock—Quinine—malaria	0.000936	0.00907	CcSEcCtD
Ketamine—CYP2B6—hematopoietic system—malaria	0.000922	0.0171	CbGeAlD
Ketamine—CYP2C9—hematopoietic system—malaria	0.000913	0.0169	CbGeAlD
Ketamine—Convulsion—Quinidine barbiturate—malaria	0.000911	0.00883	CcSEcCtD
Ketamine—Convulsion—Pentoxifylline—malaria	0.00091	0.00882	CcSEcCtD
Ketamine—Anorexia—Quinidine—malaria	0.000907	0.00879	CcSEcCtD
Ketamine—Anorexia—Quinine—malaria	0.000907	0.00879	CcSEcCtD
Ketamine—Hypotension—Clindamycin—malaria	0.000906	0.00878	CcSEcCtD
Ketamine—ABCB1—blood plasma—malaria	0.000891	0.0165	CbGeAlD
Ketamine—Hypotension—Quinine—malaria	0.000889	0.00861	CcSEcCtD
Ketamine—Hypotension—Quinidine—malaria	0.000889	0.00861	CcSEcCtD
Ketamine—Anaphylactic shock—Pentoxifylline—malaria	0.000857	0.0083	CcSEcCtD
Ketamine—Shock—Quinidine barbiturate—malaria	0.000844	0.00818	CcSEcCtD
Ketamine—Shock—Pentoxifylline—malaria	0.000843	0.00817	CcSEcCtD
Ketamine—CYP2C8—kidney—malaria	0.000842	0.0156	CbGeAlD
Ketamine—PTGS1—hematopoietic system—malaria	0.000833	0.0154	CbGeAlD
Ketamine—Pain—Clindamycin—malaria	0.000829	0.00804	CcSEcCtD
Ketamine—Vomiting—Sulfadiazine—malaria	0.000828	0.00802	CcSEcCtD
Ketamine—Decreased appetite—Quinine—malaria	0.000827	0.00801	CcSEcCtD
Ketamine—Decreased appetite—Quinidine—malaria	0.000827	0.00801	CcSEcCtD
Ketamine—Rash—Sulfadiazine—malaria	0.000821	0.00796	CcSEcCtD
Ketamine—Dermatitis—Sulfadiazine—malaria	0.00082	0.00795	CcSEcCtD
Ketamine—Anorexia—Quinidine barbiturate—malaria	0.000818	0.00793	CcSEcCtD
Ketamine—Anorexia—Pentoxifylline—malaria	0.000817	0.00792	CcSEcCtD
Ketamine—Hypotension—Quinidine barbiturate—malaria	0.000802	0.00777	CcSEcCtD
Ketamine—Hypotension—Pentoxifylline—malaria	0.000801	0.00776	CcSEcCtD
Ketamine—Nausea—Sulfadiazine—malaria	0.000773	0.0075	CcSEcCtD
Ketamine—CYP2B6—kidney—malaria	0.000755	0.014	CbGeAlD
Ketamine—Decreased appetite—Quinidine barbiturate—malaria	0.000746	0.00723	CcSEcCtD
Ketamine—Decreased appetite—Pentoxifylline—malaria	0.000745	0.00722	CcSEcCtD
Ketamine—Pain—Quinidine barbiturate—malaria	0.000734	0.00711	CcSEcCtD
Ketamine—OPRM1—brain—malaria	0.000702	0.013	CbGeAlD
Ketamine—CYP3A4—hematopoietic system—malaria	0.000696	0.0129	CbGeAlD
Ketamine—PTGS1—kidney—malaria	0.000683	0.0126	CbGeAlD
Ketamine—CYP2C8—blood—malaria	0.000681	0.0126	CbGeAlD
Ketamine—CYP2B6—digestive system—malaria	0.000641	0.0119	CbGeAlD
Ketamine—Vomiting—Dapsone—malaria	0.000637	0.00618	CcSEcCtD
Ketamine—CYP2C9—digestive system—malaria	0.000635	0.0117	CbGeAlD
Ketamine—Vomiting—Clindamycin—malaria	0.000616	0.00597	CcSEcCtD
Ketamine—Rash—Clindamycin—malaria	0.000611	0.00592	CcSEcCtD
Ketamine—Dermatitis—Clindamycin—malaria	0.000611	0.00592	CcSEcCtD
Ketamine—CYP2B6—blood—malaria	0.000611	0.0113	CbGeAlD
Ketamine—Vomiting—Quinine—malaria	0.000605	0.00586	CcSEcCtD
Ketamine—Vomiting—Quinidine—malaria	0.000605	0.00586	CcSEcCtD
Ketamine—CYP2C9—blood—malaria	0.000605	0.0112	CbGeAlD
Ketamine—Rash—Quinine—malaria	0.0006	0.00581	CcSEcCtD
Ketamine—Rash—Quinidine—malaria	0.0006	0.00581	CcSEcCtD
Ketamine—Dermatitis—Quinidine—malaria	0.000599	0.00581	CcSEcCtD
Ketamine—Dermatitis—Quinine—malaria	0.000599	0.00581	CcSEcCtD
Ketamine—Nausea—Dapsone—malaria	0.000595	0.00577	CcSEcCtD
Ketamine—PTGS1—digestive system—malaria	0.000579	0.0107	CbGeAlD
Ketamine—Nausea—Clindamycin—malaria	0.000576	0.00558	CcSEcCtD
Ketamine—CYP3A4—kidney—malaria	0.00057	0.0106	CbGeAlD
Ketamine—Nausea—Quinidine—malaria	0.000565	0.00548	CcSEcCtD
Ketamine—Nausea—Quinine—malaria	0.000565	0.00548	CcSEcCtD
Ketamine—PTGS1—blood—malaria	0.000552	0.0102	CbGeAlD
Ketamine—Vomiting—Quinidine barbiturate—malaria	0.000546	0.00529	CcSEcCtD
Ketamine—Vomiting—Pentoxifylline—malaria	0.000545	0.00528	CcSEcCtD
Ketamine—Rash—Quinidine barbiturate—malaria	0.000541	0.00525	CcSEcCtD
Ketamine—Dermatitis—Quinidine barbiturate—malaria	0.000541	0.00524	CcSEcCtD
Ketamine—Rash—Pentoxifylline—malaria	0.00054	0.00524	CcSEcCtD
Ketamine—Dermatitis—Pentoxifylline—malaria	0.00054	0.00523	CcSEcCtD
Ketamine—CYP2C8—liver—malaria	0.000532	0.00985	CbGeAlD
Ketamine—SLC6A2—brain—malaria	0.000514	0.00952	CbGeAlD
Ketamine—Nausea—Quinidine barbiturate—malaria	0.00051	0.00494	CcSEcCtD
Ketamine—Nausea—Pentoxifylline—malaria	0.000509	0.00493	CcSEcCtD
Ketamine—ABCB1—hematopoietic system—malaria	0.000493	0.00912	CbGeAlD
Ketamine—CYP3A4—digestive system—malaria	0.000484	0.00896	CbGeAlD
Ketamine—CYP2B6—liver—malaria	0.000477	0.00884	CbGeAlD
Ketamine—CYP2C9—liver—malaria	0.000473	0.00875	CbGeAlD
Ketamine—DRD2—brain—malaria	0.000469	0.00867	CbGeAlD
Ketamine—CYP3A4—blood—malaria	0.000461	0.00853	CbGeAlD
Ketamine—TACR1—Peptide GPCRs—ACKR1—malaria	0.00043	0.0452	CbGpPWpGaD
Ketamine—CYP2C8—brain—malaria	0.000422	0.00782	CbGeAlD
Ketamine—ABCB1—kidney—malaria	0.000404	0.00747	CbGeAlD
Ketamine—CYP2B6—brain—malaria	0.000379	0.00701	CbGeAlD
Ketamine—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000365	0.0384	CbGpPWpGaD
Ketamine—CYP3A4—liver—malaria	0.000361	0.00667	CbGeAlD
Ketamine—ABCB1—digestive system—malaria	0.000343	0.00634	CbGeAlD
Ketamine—PTGS1—brain—malaria	0.000343	0.00634	CbGeAlD
Ketamine—ABCB1—blood—malaria	0.000326	0.00604	CbGeAlD
Ketamine—ABCB1—bone marrow—malaria	0.000316	0.00585	CbGeAlD
Ketamine—ABCB1—liver—malaria	0.000255	0.00472	CbGeAlD
Ketamine—OPRD1—Peptide GPCRs—ACKR1—malaria	0.000242	0.0255	CbGpPWpGaD
Ketamine—OPRK1—Peptide GPCRs—ACKR1—malaria	0.000212	0.0223	CbGpPWpGaD
Ketamine—ABCB1—brain—malaria	0.000203	0.00375	CbGeAlD
Ketamine—TACR1—Peptide ligand-binding receptors—ACKR1—malaria	0.000202	0.0213	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—FCGR2A—malaria	0.000191	0.0201	CbGpPWpGaD
Ketamine—OPRM1—Peptide GPCRs—ACKR1—malaria	0.000179	0.0189	CbGpPWpGaD
Ketamine—GRIN2C—Alzheimers Disease—FAS—malaria	0.000151	0.0159	CbGpPWpGaD
Ketamine—PTGS1—Overview of nanoparticle effects—CRP—malaria	0.000149	0.0156	CbGpPWpGaD
Ketamine—GRIN2D—Alzheimers Disease—FAS—malaria	0.00014	0.0148	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—HBB—malaria	0.000139	0.0146	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	0.000136	0.0143	CbGpPWpGaD
Ketamine—PTGS1—Arachidonic acid metabolism—HPGDS—malaria	0.000132	0.0139	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—FCGR2A—malaria	0.000132	0.0138	CbGpPWpGaD
Ketamine—GRIN2A—Alzheimers Disease—FAS—malaria	0.000115	0.0121	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—IL4—malaria	0.000115	0.0121	CbGpPWpGaD
Ketamine—OPRD1—Peptide ligand-binding receptors—ACKR1—malaria	0.000114	0.012	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—ACKR1—malaria	0.000103	0.0109	CbGpPWpGaD
Ketamine—GRIN1—Alzheimers Disease—FAS—malaria	0.0001	0.0106	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—ACKR1—malaria	9.99e-05	0.0105	CbGpPWpGaD
Ketamine—GRIN2B—Alzheimers Disease—FAS—malaria	9.79e-05	0.0103	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—TLR4—malaria	9.5e-05	0.01	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—IL10—malaria	9.43e-05	0.00992	CbGpPWpGaD
Ketamine—SLC6A2—NRF2 pathway—G6PD—malaria	9.38e-05	0.00987	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—ICAM1—malaria	9.11e-05	0.00958	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—NOS2—malaria	9.04e-05	0.00951	CbGpPWpGaD
Ketamine—GRIN2C—Alzheimers Disease—IL1B—malaria	8.82e-05	0.00928	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC4A1—malaria	8.75e-05	0.00921	CbGpPWpGaD
Ketamine—CYP2C8—Arachidonic acid metabolism—HPGDS—malaria	8.52e-05	0.00897	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—ACKR1—malaria	8.44e-05	0.00888	CbGpPWpGaD
Ketamine—OPRM1—IL4-mediated signaling events—IL10—malaria	8.23e-05	0.00866	CbGpPWpGaD
Ketamine—OPRM1—IL4-mediated signaling events—CD40LG—malaria	8.23e-05	0.00866	CbGpPWpGaD
Ketamine—GRIN2D—Alzheimers Disease—IL1B—malaria	8.2e-05	0.00863	CbGpPWpGaD
Ketamine—OPRM1—IL4-mediated signaling events—IL4—malaria	8.01e-05	0.00843	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—IL4—malaria	7.9e-05	0.00832	CbGpPWpGaD
Ketamine—GRIN1—EPH-Ephrin signaling—KDR—malaria	7.86e-05	0.00827	CbGpPWpGaD
Ketamine—SLC6A2—Monoamine Transport—IL1B—malaria	7.81e-05	0.00822	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—SCARB1—malaria	7.71e-05	0.00811	CbGpPWpGaD
Ketamine—GRIN2B—EPH-Ephrin signaling—KDR—malaria	7.66e-05	0.00806	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	7.64e-05	0.00804	CbGpPWpGaD
Ketamine—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	6.94e-05	0.0073	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—IFNG—malaria	6.93e-05	0.00729	CbGpPWpGaD
Ketamine—GRIN2A—Alzheimers Disease—IL1B—malaria	6.74e-05	0.00709	CbGpPWpGaD
Ketamine—PTGS1—Overview of nanoparticle effects—TNF—malaria	6.73e-05	0.00708	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	6.7e-05	0.00705	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TLR4—malaria	6.55e-05	0.00689	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—IL10—malaria	6.5e-05	0.00684	CbGpPWpGaD
Ketamine—GRIN2C—Alzheimers Disease—TNF—malaria	6.4e-05	0.00674	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—ICAM1—malaria	6.28e-05	0.00661	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—NOS2—malaria	6.23e-05	0.00656	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—IL1B—malaria	6.18e-05	0.0065	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—IL2—malaria	6.16e-05	0.00648	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—PKLR—malaria	6.15e-05	0.00648	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—CD8A—malaria	6.04e-05	0.00636	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—PKLR—malaria	6e-05	0.00631	CbGpPWpGaD
Ketamine—GRIN2D—Alzheimers Disease—TNF—malaria	5.95e-05	0.00626	CbGpPWpGaD
Ketamine—GRIN1—Alzheimers Disease—IL1B—malaria	5.88e-05	0.00618	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—ACKR1—malaria	5.82e-05	0.00612	CbGpPWpGaD
Ketamine—GRIN2B—Alzheimers Disease—IL1B—malaria	5.73e-05	0.00603	CbGpPWpGaD
Ketamine—SLC6A2—Monoamine Transport—TNF—malaria	5.67e-05	0.00596	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	5.66e-05	0.00596	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—FAS—malaria	5.48e-05	0.00576	CbGpPWpGaD
Ketamine—PTGS1—Overview of nanoparticle effects—IL6—malaria	5.43e-05	0.00571	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—ACKR1—malaria	5.3e-05	0.00558	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—ACKR1—malaria	5.1e-05	0.00537	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—IL1B—malaria	4.94e-05	0.0052	CbGpPWpGaD
Ketamine—PTGS1—Biological oxidations—HPGDS—malaria	4.91e-05	0.00517	CbGpPWpGaD
Ketamine—GRIN2A—Alzheimers Disease—TNF—malaria	4.89e-05	0.00514	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—IFNG—malaria	4.78e-05	0.00503	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—TNF—malaria	4.49e-05	0.00472	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC4A1—malaria	4.45e-05	0.00468	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—CRP—malaria	4.36e-05	0.00459	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL12B—malaria	4.35e-05	0.00458	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—ACKR1—malaria	4.31e-05	0.00454	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	4.29e-05	0.00452	CbGpPWpGaD
Ketamine—GRIN1—Alzheimers Disease—TNF—malaria	4.26e-05	0.00449	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—IL1B—malaria	4.26e-05	0.00449	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—IL2—malaria	4.25e-05	0.00447	CbGpPWpGaD
Ketamine—GRIN2B—Alzheimers Disease—TNF—malaria	4.16e-05	0.00437	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	4.01e-05	0.00422	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—HPGDS—malaria	3.75e-05	0.00394	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—IL6—malaria	3.62e-05	0.00381	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—TNF—malaria	3.59e-05	0.00378	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—CD4—malaria	3.47e-05	0.00365	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	3.44e-05	0.00362	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—IL1B—malaria	3.41e-05	0.00359	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—ACKR1—malaria	3.27e-05	0.00344	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—IL1B—malaria	3.2e-05	0.00337	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL10—malaria	3.18e-05	0.00335	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—CD40LG—malaria	3.18e-05	0.00335	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—HPGDS—malaria	3.17e-05	0.00334	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ACKR1—malaria	3.13e-05	0.0033	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL4—malaria	3.09e-05	0.00326	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TNF—malaria	3.09e-05	0.00325	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—IFNG—malaria	3.05e-05	0.00321	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—HLA-B—malaria	3.03e-05	0.00318	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—ACKR1—malaria	2.99e-05	0.00314	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—KDR—malaria	2.92e-05	0.00307	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—IL6—malaria	2.9e-05	0.00305	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—FAS—malaria	2.85e-05	0.003	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—KDR—malaria	2.85e-05	0.00299	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	2.82e-05	0.00296	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—IL1B—malaria	2.72e-05	0.00286	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—ACKR1—malaria	2.62e-05	0.00276	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—HPGDS—malaria	2.58e-05	0.00272	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	2.54e-05	0.00267	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TLR9—malaria	2.52e-05	0.00266	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—IL6—malaria	2.5e-05	0.00263	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—TNF—malaria	2.47e-05	0.0026	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—CD36—malaria	2.41e-05	0.00254	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—CD36—malaria	2.35e-05	0.00247	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	2.24e-05	0.00236	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—DECR1—malaria	2.22e-05	0.00234	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—ACKR1—malaria	2.21e-05	0.00233	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—FAS—malaria	2.18e-05	0.0023	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—KDR—malaria	2.08e-05	0.00219	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—KDR—malaria	2.03e-05	0.00214	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—IL6—malaria	2e-05	0.0021	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—TNF—malaria	1.97e-05	0.00208	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	1.96e-05	0.00206	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—DHODH—malaria	1.92e-05	0.00202	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.89e-05	0.00198	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—IL6—malaria	1.88e-05	0.00197	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IFNG—malaria	1.87e-05	0.00197	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—NOS2—malaria	1.87e-05	0.00196	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	1.81e-05	0.0019	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ACKR1—malaria	1.76e-05	0.00186	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.73e-05	0.00182	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—HPGDS—malaria	1.7e-05	0.00179	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—ACKR1—malaria	1.68e-05	0.00176	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL1B—malaria	1.67e-05	0.00176	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL2—malaria	1.66e-05	0.00175	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SLC4A1—malaria	1.63e-05	0.00172	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—IL6—malaria	1.59e-05	0.00168	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ACKR1—malaria	1.55e-05	0.00163	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—DECR1—malaria	1.53e-05	0.00161	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—DHODH—malaria	1.46e-05	0.00154	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TLR9—malaria	1.42e-05	0.0015	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	1.41e-05	0.00148	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HBB—malaria	1.39e-05	0.00146	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ACKR1—malaria	1.31e-05	0.00138	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TLR9—malaria	1.25e-05	0.00131	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC4A1—malaria	1.24e-05	0.00131	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—DHODH—malaria	1.24e-05	0.0013	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PKLR—malaria	1.24e-05	0.0013	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.22e-05	0.00128	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—IL2—malaria	1.21e-05	0.00128	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—TNF—malaria	1.21e-05	0.00127	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—DECR1—malaria	1.17e-05	0.00123	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.12e-05	0.00118	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—IL6—malaria	1.11e-05	0.00117	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL2—malaria	1.1e-05	0.00116	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—G6PD—malaria	1.1e-05	0.00116	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	1.09e-05	0.00114	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—IL6—malaria	1.08e-05	0.00114	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—DHODH—malaria	1.08e-05	0.00114	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HBB—malaria	1.06e-05	0.00111	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TLR9—malaria	1.05e-05	0.00111	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC4A1—malaria	1.05e-05	0.00111	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—DHODH—malaria	1.01e-05	0.00106	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KDR—malaria	1e-05	0.00106	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	9.91e-06	0.00104	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ACKR1—malaria	9.91e-06	0.00104	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—DECR1—malaria	9.9e-06	0.00104	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TNF—malaria	9.84e-06	0.00104	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TNF—malaria	9.59e-06	0.00101	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PKLR—malaria	9.43e-06	0.000992	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC4A1—malaria	9.17e-06	0.000965	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	9.1e-06	0.000958	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HBB—malaria	8.95e-06	0.000942	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—DECR1—malaria	8.63e-06	0.000908	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC4A1—malaria	8.57e-06	0.000902	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—G6PD—malaria	8.4e-06	0.000884	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HPGDS—malaria	8.4e-06	0.000884	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—DECR1—malaria	8.06e-06	0.000848	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TLR9—malaria	7.99e-06	0.00084	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PKLR—malaria	7.98e-06	0.00084	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—IL6—malaria	7.94e-06	0.000835	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HBB—malaria	7.8e-06	0.000821	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—DHFR—malaria	7.79e-06	0.00082	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—IL6—malaria	7.74e-06	0.000814	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SCARB1—malaria	7.71e-06	0.000811	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—IL6—malaria	7.48e-06	0.000787	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HBB—malaria	7.29e-06	0.000767	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—G6PD—malaria	7.11e-06	0.000748	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	7.02e-06	0.000739	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PKLR—malaria	6.95e-06	0.000732	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL2—malaria	6.84e-06	0.00072	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DHODH—malaria	6.65e-06	0.000699	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL2—malaria	6.51e-06	0.000686	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PKLR—malaria	6.49e-06	0.000683	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL6—malaria	6.48e-06	0.000682	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HPGDS—malaria	6.41e-06	0.000674	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2—malaria	6.21e-06	0.000654	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—G6PD—malaria	6.2e-06	0.000652	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2—malaria	6e-06	0.000631	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	5.98e-06	0.000629	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—DHFR—malaria	5.94e-06	0.000625	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SCARB1—malaria	5.88e-06	0.000619	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—G6PD—malaria	5.79e-06	0.000609	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	5.71e-06	0.000601	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KDR—malaria	5.66e-06	0.000596	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC4A1—malaria	5.65e-06	0.000595	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—malaria	5.45e-06	0.000573	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HPGDS—malaria	5.42e-06	0.000571	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DECR1—malaria	5.31e-06	0.000559	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—malaria	5.07e-06	0.000533	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—DHFR—malaria	5.03e-06	0.00053	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SCARB1—malaria	4.98e-06	0.000524	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KDR—malaria	4.96e-06	0.000522	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CD36—malaria	4.84e-06	0.000509	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HBB—malaria	4.81e-06	0.000506	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HPGDS—malaria	4.73e-06	0.000497	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—malaria	4.6e-06	0.000484	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HPGDS—malaria	4.41e-06	0.000465	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—DHFR—malaria	4.38e-06	0.000461	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SCARB1—malaria	4.34e-06	0.000457	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PKLR—malaria	4.28e-06	0.000451	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KDR—malaria	4.19e-06	0.000441	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—DHFR—malaria	4.1e-06	0.000431	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SCARB1—malaria	4.05e-06	0.000427	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—malaria	3.84e-06	0.000404	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—malaria	3.83e-06	0.000403	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—G6PD—malaria	3.82e-06	0.000402	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CD36—malaria	3.69e-06	0.000388	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—malaria	3.67e-06	0.000386	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—malaria	3.65e-06	0.000384	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—malaria	3.49e-06	0.000367	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—malaria	3.22e-06	0.000339	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—malaria	3.2e-06	0.000337	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KDR—malaria	3.18e-06	0.000335	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CD36—malaria	3.13e-06	0.000329	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HPGDS—malaria	2.91e-06	0.000306	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CD36—malaria	2.72e-06	0.000287	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—malaria	2.72e-06	0.000286	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—malaria	2.71e-06	0.000285	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DHFR—malaria	2.7e-06	0.000284	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SCARB1—malaria	2.67e-06	0.000281	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CD36—malaria	2.54e-06	0.000268	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—malaria	2.16e-06	0.000227	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—malaria	2.06e-06	0.000217	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—malaria	2.05e-06	0.000216	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—malaria	1.89e-06	0.000199	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CD36—malaria	1.68e-06	0.000177	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—malaria	1.6e-06	0.000168	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—malaria	1.21e-06	0.000127	CbGpPWpGaD
